Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
293
archived clinical trials in
Benign Prostate Hyperplasia

A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia
Status: Archived
Clinical Trial Facility
2093
mi
from 43215
Santa Clara, CA
A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
2093
mi
from 43215
Santa Clara, CA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Veterans Affairs Medical Center, Washington D.C.
329
mi
from 43215
Washington D.C.,
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center, Washington D.C.
329
mi
from 43215
Washington D.C.,
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
659
mi
from 43215
Fayetteville, AK
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
659
mi
from 43215
Fayetteville, AK
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Dana-Farber / Harvard Cancer Center
643
mi
from 43215
Boston, MA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
643
mi
from 43215
Boston, MA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Memorial Hospital of Rhode Island
621
mi
from 43215
Pawtucket, RI
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Memorial Hospital of Rhode Island
621
mi
from 43215
Pawtucket, RI
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
554
mi
from 43215
Hartford, CT
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
554
mi
from 43215
Hartford, CT
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
1506
mi
from 43215
Idaho Falls, ID
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1506
mi
from 43215
Idaho Falls, ID
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
700
mi
from 43215
Scarborough, ME
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
700
mi
from 43215
Scarborough, ME
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
University of Vermont College of Medicine
590
mi
from 43215
Burlington, VT
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
University of Vermont College of Medicine
590
mi
from 43215
Burlington, VT
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
679
mi
from 43215
Topeka, KA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
679
mi
from 43215
Topeka, KA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
798
mi
from 43215
Alexandria, LA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
798
mi
from 43215
Alexandria, LA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
206
mi
from 43215
Lansing, MI
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
206
mi
from 43215
Lansing, MI
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
1612
mi
from 43215
Missoula, MT
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
1612
mi
from 43215
Missoula, MT
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
89
mi
from 43215
Cincinnati, OH
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
89
mi
from 43215
Cincinnati, OH
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
735
mi
from 43215
Muskogee, OK
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
735
mi
from 43215
Muskogee, OK
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
New York Methodist Hospital
478
mi
from 43215
Brooklyn, NY
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
478
mi
from 43215
Brooklyn, NY
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
362
mi
from 43215
Chattanooga, TN
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
A Study in Men With Benign Prostatic Hyperplasia
A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 Weeks in Men With Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Status: Archived
Clinical Trial Facility
2093
mi
from 43215
Santa Clara, CA
Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
2093
mi
from 43215
Santa Clara, CA
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Dana-Farber / Harvard Cancer Center
643
mi
from 43215
Boston, MA
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
643
mi
from 43215
Boston, MA
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Clinical Research Facility
798
mi
from 43215
Alexandria, LA
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
798
mi
from 43215
Alexandria, LA
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
A Phase 3b, Randomized, Double-blind, Placebo-controlled Parallel-design Study to Evaluate the Efficacy and Safety of Tadalafil Co-administered With Finasteride for 6 Months in Men With Lower Urinary Tract Symptoms and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
937
mi
from 43215
Fort Worth, TX
A Study in Benign Prostatic Hyperplasia
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
700
mi
from 43215
Scarborough, ME
A Study in Benign Prostatic Hyperplasia
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
700
mi
from 43215
Scarborough, ME
A Study in Benign Prostatic Hyperplasia
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status: Archived
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
A Study in Benign Prostatic Hyperplasia
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
A Study in Benign Prostatic Hyperplasia
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status: Archived
New York Methodist Hospital
478
mi
from 43215
Brooklyn, NY
A Study in Benign Prostatic Hyperplasia
A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
478
mi
from 43215
Brooklyn, NY
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Chesapeake Urology
349
mi
from 43215
Baltimore, MD
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Chesapeake Urology
349
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
344
mi
from 43215
Danville, PA
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
344
mi
from 43215
Danville, PA
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Urology Associates of Denver
1162
mi
from 43215
Englewood, CO
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Urology Associates of Denver
1162
mi
from 43215
Englewood, CO
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Sheldon J. Freedman, M.D., Ltd.
1767
mi
from 43215
Las Vegas, NV
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Sheldon J. Freedman, M.D., Ltd.
1767
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Carolina Urologic Research Center
487
mi
from 43215
Myrtle Beach, SC
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Carolina Urologic Research Center
487
mi
from 43215
Myrtle Beach, SC
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
U.T. Southwestern Medical Center
910
mi
from 43215
Dallas, TX
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
U.T. Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Scott and White Healthcare
1018
mi
from 43215
Temple, TX
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Scott and White Healthcare
1018
mi
from 43215
Temple, TX
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Genesis Research
1951
mi
from 43215
San Diego, CA
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Genesis Research
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Shahram S. Gholami MD - A Professional Corp.
2109
mi
from 43215
San Jose, CA
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Shahram S. Gholami MD - A Professional Corp.
2109
mi
from 43215
San Jose, CA
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Advanced Urology Institute
751
mi
from 43215
Daytona Beach, FL
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Advanced Urology Institute
751
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Pinellas Urology Inc
842
mi
from 43215
Saint Petersburg, FL
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Pinellas Urology Inc
842
mi
from 43215
Saint Petersburg, FL
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Jean Brown Research
1512
mi
from 43215
Salt Lake City, UT
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Jean Brown Research
1512
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated:  12/31/1969
Figtree Private Hospital
9491
mi
from 43215
Figtree,
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Status: Enrolling
Updated: 12/31/1969
Figtree Private Hospital
9491
mi
from 43215
Figtree,
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated:  12/31/1969
Chesapeake Urology
349
mi
from 43215
Baltimore, MD
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Chesapeake Urology
349
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated:  12/31/1969
Sheldon J. Freedman, M.D., Ltd.
1767
mi
from 43215
Las Vegas, NV
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Sheldon J. Freedman, M.D., Ltd.
1767
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated:  12/31/1969
Carolina Urologic Research Center
487
mi
from 43215
Myrtle Beach, SC
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Carolina Urologic Research Center
487
mi
from 43215
Myrtle Beach, SC
Click here to add this to my saved trials